Enanta Pharmaceuticals (ENTA) EBT (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted EBT of -$13.1 million for Q1 2026, down 9.82% on a QoQ basis from -$11.9 million in Q4 2025, and up 45.37% year-over-year from -$9.0 million in Q1 2025.
Enanta Pharmaceuticals (ENTA) EBT (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals' EBT history runs 15 years deep, the most recent figure standing at -$13.1 million for Q1 2026.
- Quarterly EBT rose 45.37% year-over-year to -$13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61.9 million (up 37.42% YoY) and the FY2025 annual result came in at -$83.5 million, up 29.07% from the prior year.
- EBT was -$13.1 million for Q1 2026 at Enanta Pharmaceuticals, down from -$11.9 million in the prior quarter.
- Across five years, EBT topped out at -$11.9 million in Q4 2025 and bottomed at -$37.6 million in Q1 2023.
- A 5-year average of -$26.4 million and a median of -$29.0 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT declined 17.26% — and 2025, when it soared 47.53%.
- Enanta Pharmaceuticals' EBT stood at -$29.0 million in 2022, then declined by 17.26% to -$34.0 million in 2023, then surged by 33.27% to -$22.7 million in 2024, then surged by 47.53% to -$11.9 million in 2025, then dropped by 9.82% to -$13.1 million in 2026.
- Business Quant data shows ENTA's EBT at -$13.1 million in Q1 2026, -$11.9 million in Q4 2025, and -$18.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | -13.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.08 Mn |
| Dec 31, 2025 | -11.91 Mn |
| Sep 30, 2025 | -18.67 Mn |
| Jun 30, 2025 | -18.23 Mn |
| Mar 31, 2025 | -23.95 Mn |
| Dec 31, 2024 | -22.71 Mn |
| Sep 30, 2024 | -29.19 Mn |
| Jun 30, 2024 | -23.05 Mn |
| Mar 31, 2024 | -31.52 Mn |
| Dec 31, 2023 | -34.03 Mn |
| Sep 30, 2023 | -29.52 Mn |
| Jun 30, 2023 | -34.84 Mn |
| Mar 31, 2023 | -37.61 Mn |
| Dec 31, 2022 | -29.02 Mn |
| Sep 30, 2022 | -26.33 Mn |
| Jun 30, 2022 | -32.15 Mn |
| Mar 31, 2022 | -33.59 Mn |
| Dec 31, 2021 | -30.15 Mn |
| Sep 30, 2021 | -33.39 Mn |
| Jun 30, 2021 | -33.41 Mn |